Lung function decline in male heavy smokers relates to baseline airflow obstruction severity

Chest

Volumn 142, Issue 6, 2012, Pages 1530-1538

  Mohamed Hoesein, Firdaus A A ^a   Zanen, Pieter ^a   Boezen, H Marike ^c   Groen, Harry J M ^c   Van Ginneken, Bram ^b,d   De Jong, Pim A ^b   Postma, Dirkje S ^c   Lammers, Jan Willem J ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^c UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^d RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AIRWAY OBSTRUCTION; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE SEVERITY; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; HUMAN; LUNG FUNCTION; LUNG FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; MAXIMAL EXPIRATORY FLOW; PRIORITY JOURNAL; SMOKING; SMOKING HABIT;

EID: 84870614415     PISSN: 00123692     EISSN: 19313543     Source Type: Journal    
DOI: 10.1378/chest.11-2837     Document Type: Article

References (41)

1. Murray CJ, Lopez AD. Alternative projections of mortality and disability by cause 1990-2020: Global Burden of Disease Study. Lancet. 1997;349(9064):1498- 1504. (Pubitemid 27216360)
2. Rabe KF, Hurd S, Anzueto A, et al Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am. Respir Crit Care Med. 2007;176(6):532-555. (Pubitemid 47403272)
3. Celli BR, MacNee W; ATS/ERS Task Force. Standards for the diagnosis and treatment of patients with COPD:. summary of the ATS/ERS position paper. Eur Respir J. 2004;23(6):932-946. (Pubitemid 38807371)
4. Mannino DM. Defining chronic obstructive pulmonary disease... and the elephant in the room. Eur Respir J. 2007;30(2):189-190. (Pubitemid 47194169)
5. Miller MR, Pedersen OF, Pellegrino R, Brusasco V. Debating the definition of airflow obstruction: time to move on? Eur Respir J. 2009;34(3):527-528.
6. Gould GA, MacNee W, McLean A, et al. CT measurements of lung density in life can quantitate distal airspace enlargement-an essential defining feature of human emphysema. Am Rev Respir Dis. 1988;137(2):380-392. (Pubitemid 18050189)
7. Tashkin DP, Celli B, Senn S, et al UPLIFT Study Investigators. 4-year trial of tiotropium in chronic obstructive pulmonary disease. Engl. Med. 2008;359(15):1543-1554.
8. Celli BR, Thomas NE, Anderson JA, et al. Effect of pharmacotherapy on rate of decline of lung function in chronic obstructive pulmonary disease: results from the TORCH study. Am. Respir Crit Care Med. 2008;178(4):332-338.
9. van Iersel CA, de Koning HJ, Draisma G, et al. Risk-based selection from the general population in. screening trial: selection criteria, recruitment and power for the Dutch-Belgian randomised lung cancer multi-slice CT screening trial (NELSON). Int. Cancer. 2007;120(4):868-874. (Pubitemid 46175408)
10. van Klaveren RJ, Oudkerk M, Prokop M, et al. Management of lung nodules detected by volume CT scanning. Engl. Med. 2009;361(23):2221-2229.
11. Miller MR, Crapo R, Hankinson J, et al ATS/ERS Task Force. General considerations for lung function testing. Eur Respir J. 2005;26(1):153-161. (Pubitemid 40945944)
12. Quanjer PH, Tammeling GJ, Cotes JE, Pedersen OF, Peslin R, Yernault JC; Official Statement of the European Respiratory Society. Lung volumes and forced ventilatory flows. Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Eur Respir. Suppl. 1993;16:5-40.
13. Mohamed Hoesein FA, de Hoop B, Zanen P, et al. CT-quantified emphysema in male heavy smokers: association with lung function decline. Thorax. 2011;66(9):782-787.
14. van Rikxoort EM, Prokop M, de Hoop B, Viergever MA, Pluim JP, van Ginneken B. Automatic segmentation of the pulmonary lobes from fissures, airways, and lung borders: evaluation of robustness against missing data. Med Image Comput Comput Assist Interv. 2009;12(pt 1):263-271.
15. Coxson HO. Quantitative chest tomography in COPD research: chairman's summary. Proc Am Thorac Soc. 2008;5(9):874-877.
16. Coxson HO. Quantitative computed tomography assessment of airway wall dimensions: current status and potential applications for phenotyping chronic obstructive pulmonary disease. Proc Am Thorac Soc 2008;5(9):940-945.
17. Newell JD Jr, Hogg JC, Snider GL. Report of. workshop: quantitative computed tomography scanning in longitudinal studies of emphysema. Eur Respir J. 2004;23(5):769-775. (Pubitemid 38618151)
18. Gould GA, MacNee W, McLean A, et al. CT measurements of lung density in life can quantitate distal airspace enlargement. an essential defining feature of human emphysema. Am Rev Respir Dis 1988;137(2):380-392. (Pubitemid 18050189)
19. Parr DG, Stoel BC, Stolk J, Stockley RA. Validation of computed tomographic lung densitometry for monitoring emphysema in alpha1-antitrypsin deficiency. Thorax 2006;61(6):485-490. (Pubitemid 43901517)
20. Parr DG, Sevenoaks M, Deng C, Stoel BC, Stockley RA. Detection of emphysema progression in alpha 1-antitrypsin deficiency using CT densitometry; methodological advances. Respir Res. 2008;9:21.
21. Vestbo J, Edwards LD, Scanlon PD, et al ECLIPSE Investigators. Changes in forced expiratory volume in. second over time in COPD. Engl. Med. 2011;365(13):1184-1192.
22. Donaldson GC, Seemungal TA, Patel IS, et al. Airway and systemic inflammation and decline in lung function in patients with COPD. Chest. 2005;128(4):1995-2004. (Pubitemid 41507533)
23. Higashimoto Y, Iwata T, Okada M, Satoh H, Fukuda K, Tohda Y. Serum biomarkers as predictors of lung function decline in chronic obstructive pulmonary disease. Respir Med. 2009;103(8):1231-1238.
24. Fletcher C, Peto R. The natural history of chronic airflow obstruction. BMJ. 1977;1(6077):1645-1648. (Pubitemid 8124466)
25. Burrows B, Knudson RJ, Camilli AE, Lyle SK, Lebowitz MD. The "horse-racing effect"and predicting decline in forced expiratory volume in one second from screening spirometry. Am Rev Respir Dis. 1987;135(4):788-793. (Pubitemid 17055502)
26. Linn RL, Slinde JA. The determination of the significance of change between pre-and posttesting periods. Rev Educ Res. 1977;47(1):121-150.
27. Mannino DM, Reichert MM, Davis KJ. Lung function decline and outcomes in an adult population. Am. Respir Crit Care Med. 2006;173(9):985-990.
28. Scanlon PD, Connett JE, Waller LA, Altose MD, Bailey WC, Buist AS. Smoking cessation and lung function in mild-to-moderate chronic obstructive pulmonary disease. The Lung Health Study. Am. Respir Crit Care Med. 2000;161(2 pt 1):381-390. (Pubitemid 30129442)
29. Cosio M, Ghezzo H, Hogg JC, et al. The relations between structural changes in small airways and pulmonary-function tests. Engl. Med. 1978;298(23):1277-1281. (Pubitemid 8361451)
30. Wright JL, Lawson LM, Paré PD, Kennedy S, Wiggs B, Hogg JC. The detection of small airways disease. Am Rev Respir Dis. 1984;129(6):989-994. (Pubitemid 14111759)
31. Amin K, Ekberg-Jansson A, Löfdahl CG, Venge P. Relationship between inflammatory cells and structural changes in the lungs of asymptomatic and never smokers:. biopsy study. Thorax. 2003;58(2):135-142. (Pubitemid 36183001)
32. Hogg JC, Chu F, Utokaparch S, et al. The nature of small-airway obstruction in chronic obstructive pulmonary disease. Engl. Med. 2004;350(26):2645-2653. (Pubitemid 38787999)
33. Pierrou S, Broberg P, O'Donnell RA, et al. Expression of genes involved in oxidative stress responses in airway epithelial cells of smokers with chronic obstructive pulmonary disease. Am. Respir Crit Care Med. 2007;175(6):577-586. (Pubitemid 46438942)
34. Gosselink JV, Hayashi S, Elliott WM, et al. Differential expression of tissue repair genes in the pathogenesis of chronic obstructive pulmonary disease. Am. Respir Crit Care Med. 2010;181(12):1329-1335.
35. Suissa S. Lung function decline in COPD trials: bias from regression to the mean. Eur Respir J. 2008;32(4):829-831.
36. Davis CE. The effect of regression to the mean in epidemiologic and clinical studies. Am. Epidemiol. 1976;104(5):493-498.
37. Vickers AJ, Altman DG. Statistics notes: analysing controlled trials with baseline and follow up measurements. BMJ. 2001;323(7321):1123-1124. (Pubitemid 33063362)
38. Munnik P, Zanen P, Lammers JW. comparison of lung function equipment with emphasis on interchangeability and methods. Physiol Meas. 2006;27(6):445-455.
39. Bellomi M, Rampinelli C, Veronesi G, et al. Evolution of emphysema in relation to smoking. Eur Radiol. 2010;20(2):286-292.
40. Grydeland TB, Dirksen A, Coxson HO, et al. Quantitative computed tomography: emphysema and airway wall thickness by sex, age and smoking. Eur Respir J. 2009;34(4):858-865.
41. Soejima K, Yamaguchi K, Kohda E, et al. Longitudinal follow-up study of smoking-induced lung density changes by high-resolution computed tomography. Am. Respir Crit Care Med. 2000;161(4 pt 1):1264-1273. (Pubitemid 30243840)